ICD10 code: G40.309
ICD9 code: 277.41
Pyridoxine-Dependent Epilepsy is a rare genetic disorder characterized by seizures that are resistant to typical anti-seizure medications but can be controlled with vitamin B6 (pyridoxine) supplementation. The ICD10 code G40.309 represents this condition in the International Classification of Diseases, 10th Revision. In the older ICD9 coding system, the code 277.41 is used to identify Pyridoxine-Dependent Epilepsy.
Pyridoxine-Dependent Epilepsy is a rare genetic disorder that affects the metabolism of vitamin B6, leading to seizures that can be effectively managed with vitamin B6 supplementation. In the International Classification of Diseases, Tenth Revision (ICD-10), the code for Pyridoxine-Dependent Epilepsy is G40.A1.
However, it should be noted that ICD-9 codes are no longer in use, as they were replaced by ICD-10 codes in October 2015. In the previous ICD-9 system, Pyridoxine-Dependent Epilepsy was classified under code 277.1, which encompassed various disorders related to disorders of amino acid metabolism.
Diagnosis and coding of medical conditions are crucial for accurate medical recordkeeping, billing, and statistical purposes. Healthcare professionals utilize these codes to communicate information about a patient's condition effectively. By assigning the appropriate ICD-10 code, such as G40.A1 for Pyridoxine-Dependent Epilepsy, healthcare providers can ensure accurate documentation and facilitate effective communication among medical teams.
It is important to consult with a healthcare professional or a certified medical coder to obtain the most up-to-date and accurate information regarding medical coding and classification systems, as these systems are periodically updated to reflect advancements in medical knowledge and terminology.